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ABSTRACT 
 
Locally advanced oral cavity cancer is managed in multidisciplinary setting including surgery followed by 
postoperative radiotherapy (PORT) and chemotherapy. We also follow the same protocol however during the active 
treatment only our patients had recurrence of disease. We enrolled 16 cases of locally advanced oral cavity cancer 
seen from September to November 2015 at our Radiation Oncology department. Most common presentation is age 
group of 31-40 years and 14 cases were males out of 16. The pattern of presentation included cases as 9 carcinoma 
tongue, 5 carcinoma buccal mucosa, 1 carcinoma angle of mouth and 1 carcinoma of lower alveolus. All these 
patients were operated and referred for PORT. The dose of PORT planned was 60 Gy/30# for 6 weeks along with 
concurrent cisplatin 30mg/m2 weekly. All these patients by the mid of the treatment developed nodal recurrence 
confirmed on Biopsy. When the high risk factors were extrapolated it was found that depth was more than 1 cm, 
base of resection (BOR)  was also close all being <0.5 cm and margins being very close the cut off being 0.3 cm. All 
these patients had their PORT started after 7 weeks of surgery. Age <45 years, depth >1 cm, BOR <0.5 cm and close 
margins with cut off  0.3 cm, perinodal extension or otherwise presence of perineural invasion were poor prognosis 
features determining aggressiveness of disease. This study gave an impetus to explore more in such type of poor 
prognosis patients and we look forward for more insight. 
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Introduction 
 
Head and neck cancers are commonest presentation 
with about nearly 40,000 new cases detected annually 
and most of these patients are in advanced stage at 
presentation only. Tobacco and alcohol overuse are 
major causative factors for head and neck carcinoma. 
[1,2]  In India people are usually addicted with tobacco 
in various forms like chewing and smoking. Majority 
of cases present in very advanced stages with more 
than 70% of cases at presentation having either large 
primary or large nodes or both. Usually in such 
advanced cases if the disease is resectable surgery is 
done first followed by adjuvant therapy including 
radiation and chemotherapy according to the 
indications present.  Postoperative radiotherapy is  
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given when the histopathology report shows tumor size 
more than T 2 stage, lymphovascular involvement, 
perineural involvement, surgical margin positivity,or 
close margins node positivity, perinodal extension and 
bone involvement. [3,4,5] In patients where multiple 
nodes are positive or close margins or positive margins 
status is there, they are additionally offered concurrent 
chemotherapy. We also follow this same protocol 
however in this study during the active postoperative 
radiotherapy and chemotherapy protocol only patients 
started developing recurrence of the disease. Thus we 
conducted this study to extrapolate in detail the high 
risk poor prognostic features responsible for early 
recurrence in these patients. We expect that with the 
results and experience from this study we can choose 
such high risk cases requiring immediate attention. 
 
Materials and methods 
 
We have enrolled 16 cases of locally advanced oral 
cavity cancer cases seen from September 2015 to 
November 2015 at our department of Radiation 
 Asian Pac. J. Health Sci., 2015; 2(4S):32-35                                         e-ISSN: 2349-0659,   p-ISSN: 2350-0964                         
____________________________________________________________________________________________________________________________________________  
 ____________________________________________________________________________________________________________________________________________ 
Patel et al     ASIAN PACIFIC JOURNAL OF HEALTH SCIENCES, 2015; 2(4S): 32-35 
www.apjhs.com      33 
 
Oncology being referred for postoperative radiotherapy 
treatment. Males dominated in this study with total 14 
cases out of 16 cases. Most common age presentation 
is age group of 31-40 years. The pattern of presentation 
included 9 carcinoma tongue cases, 5 carcinoma buccal 
mucosa cases, 1 carcinoma angle of mouth and 1 
carcinoma of lower alveolus. All these patients were 
locally advanced and were taken for surgery first. For 
the 9 patients of carcinoma of tongue surgery done was 
ranging from partial to total glossectomy with bilateral 
modified neck dissection. 5 patients of carcinoma 
buccal mucosa were operated for Commando operation 
1 patient of carcinoma of angle of mouth and one 
patient of carcinoma of lower alveolus were operated 
for wide local excision with marginal mandibulectomy 
with ipsilateral modified neck dissection. All these 
patients after surgery were referred to us for 
postoperative radiotherapy. These patients after proper 
dental evaluation were taken for postoperative 
radiotherapy according to the indications of adjuvant 
radiotherapy including advanced T stage (T3/T4), the 
presence of lymphovascular positivity, the presence of 
perineural positivity, positive or close surgical margins, 
lymph node positivity, extracapsular nodal extension 
and bone positivity. The dose of postoperative 
radiotherapy planned was 60Gy/30# with 2 
dimensional radiotherapy techniques with conventional 
dose of 2 Gy/# for 6 weeks. Because of poor prognostic 
factors these patients were also offered concurrent 
cisplatin 30mg/m2 weekly with post operative 
radiotherapy. Because of huge workload and being a 
busy regional cancer centre patient’s number is huge. 
Thus all these patients after surgery and taking utmost 
measures of getting the patient undergo thorough 
dental evaluation and preparing proper immobilization 
masks including plaster of paris cast preparation these 
patients were started for their postoperative 
radiotherapy mostly after 7 weeks of surgery. On day 
of starting radiotherapy, planning was done and patient 
was thoroughly counseled for maintaining proper oral 
hygiene and ensured their adequate analgesia too. 
Hygiene is very important for causation of head and 
neck cancer and also for determining responsiveness of 
therapy. [6] During their postoperative radiotherapy 
treatment when patients used to come for regular 
checkups we observed recurrences. 5 of the 16 patients 
before they even complete their second week of 
postoperative radiotherapy developed nodal recurrence. 
When we observed this nodular swelling we got it 
biopsied and it turned out to be metastatic squamous 
cell carcinoma. We stopped the postoperative 
radiotherapy treatment and then referred the patient to 
medical outpatient department for starting palliative 
chemotherapy. All these patients had nodal recurrence 
of more than 2 cm and hard ones which even surgical 
people found difficult to reoperate. Another 9 patients 
developed recurrence after in their third week of 
postoperative radiotherapy treatment but because of 
failure of any further surgical intervention 
postoperative radiotherapy was stopped and advised 
palliative chemotherapy after biopsy confirmation of 
recurrent metastatic node. One patient developed 
recurrence in fourth week and last patient developed 
recurrence in fifth week but despite nearing their 
completion of postoperative radiotherapy treatment the 
radiotherapy was stopped and started on palliative 
chemotherapy after histopathological confirmation. 
Two out of sixteen patients had Level IV nodal 
recurrence both of them with primary in carcinoma of 
tongue. One patients had level V nodal recurrence with 
primary from buccal mucosa rest all patients had level 
II nodal recurrence. 
 
Result 
 
We tried to extrapolate their histopathological findings 
and tried to study the biology of the disease as the 
recurrence was very quick keeping us also in 
astonishment and as a lesson to learn for future to 
concentrate more on these types of patients requiring 
immediate attention. All these patients had nodal 
recurrence confirmed on Biopsy. When the high risk 
factors were extrapolated it was found that depth more 
than 1 cm was the commonest finding amongst all 
these cases. All these patients had their postoperative 
radiotherapy treatment started after 6 weeks of surgery 
implying time factor being most important in 
determining prognosis of patients. Base of resection 
was also very close all being <0.5 cm and margins 
being very close the cut off being 0.3 cm were also 
determining mostly the early recurrence in these 
patients. All patients were young with age <45 years of 
age indicating at young age disease behaves more 
aggressively. Out of 16 cases 14 were males but this 
finding being coincidental as mostly oral cancers were 
found in males because of more use of tobacco. 
 
Discussion 
 
Head and neck cancers are the most common cancers 
in India with majority of cases being advanced in 
which surgery is offered first for resectable ones 
followed by adjuvant therapy according to the 
indications present. Postoperative Radiotherapy is 
standard care of treatment in such advanced cases. [3] 
Role of adjuvant chemotherapy was explored by 
Cooper et al [4] and Laramore et al. [7]  The 
indications of postoperative radiotherapy include tumor 
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size more than T 2 stage, lymphovascular involvement, 
perineural involvement, surgical margin positivity,or 
close margins, node positivity, perinodal extension and 
bone involvement. Adjuvant chemotherapy is given in 
patients with multiple nodes positivity or close margins 
or with positive margins status.[8,9] We also did the 
same protocol however in this study during the active 
postoperative radiotherapy and chemotherapy protocol 
only patients started developing recurrence of the 
disease. When all the high risk features were spread out 
on a common sheet, many poor prognostic features 
were highlighted. The very obvious and first finding 
we could make out was the young age of presentation 
in this study indicating aggressiveness of disease as has 
been found in literature search too.  [10,11] Other 
significant features like depth > 1 cm was also very 
important poor prognostic deterministic factor. All the 
16 cases had depth more than 1 cm very importantly 
emphasing depth more than 1 cm as detrimental factor. 
The tumor thickness is in turn related to nodal 
involvement thus leading directly or indirectly as guide 
for aggressiveness of disease. [12] Nodal positivity 
especially when multiple nodes are positive or having 
extra capsular extension also determines chances of 
early recurrence as seen in our study where 11 cases 
out of 16 had perinodal extension. This factor is also 
studied well by Greenberg et al [13] when he shared 
his experience of carcinoma tongue cases with 
perinodal extension as aggressiveness determining 
factor. In rest cases when it was not pericapsular 
extension then even perineural invasion as an alone 
factor was important in bringing out early recurrence. 
[14]   Another common feature amongst all cases very 
obviously seen was that all patients had their 
postoperative radiotherapy started after 7 weeks of 
surgery determining timing being a very important 
issue to be addressed. Marshak et al [15] studied 
importance of starting postoperative radiotherapy 
treatment within 4-6 weeks of surgery. The logic 
behind this time factor game is the concept of tumor 
repopulation where the intention is to complete the 
treatment in as short time as possible.[16] Another way 
of dealing this time issue is to try different radiotherapy 
regimes like hyperfractionation or accelerated 
radiotherapy but these regimens ultimately lead to 
profound side effects especially when combined with 
concurrent chemotherapy eventually leading to 
treatment breaks and thereby delaying the treatment to 
be completed in stipulated time. [17]  Base of resection 
was also very close all being <0.5 cm and margins 
being very close the cut off being 0.3 cm highlighting 
its importance as poor prognostic feature. 
 
 
Conclusion 
 
Thus after studying all above high risk and poor 
prognosis features it was very much clear that young 
patients fare badly as seen in our study with all patients 
being young than 45 years of age. Other poor 
prognostic features like tumor thickness more than 1cm 
, Base of resection <0.5 cm and close margins with cut 
off  0.3 cm, perinodal extension or otherwise presence 
of perineural invasion were also important in 
determining aggressiveness of disease. Time factor had 
also an important role to play concluding that it is 
better to start postoperative radiotherapy within in 4-6 
weeks of surgery. This preliminary study gave an 
impetus to explore more in such type of poor prognosis 
patients by adding more options like adding targeted 
chemotherapy or trying some different radiotherapy 
regimens. We look forward for more insight in future 
for such cases. 
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